Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma

Clinical Laboratory

Volumn 59, Issue 9-10, 2013, Pages 1009-1015

  Li, Jianbiao ^a   Shi, Wenxia ^b   Gao, Yingtang ^b,c   Yang, Bin ^b   Jing, Xiang ^b   Shan, Shigang ^a   Wang, Yijun ^b   Du, Zhi ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN THIRD CENTRAL HOSPITAL   (China)

^c Postdoctoral Workstation of TEDA   (China)

Author keywords

Hepatocellular carcinoma; Let 7a; Micro RNA; MiRNA PCR array

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 16; MICRORNA 183; MICRORNA 196A; MICRORNA 21; MICRORNA 96; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEREGULATION; DOWN REGULATION; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; RNA FOLDING; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84886418579     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120901     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011 Mar-Apr;61(2):69-90.
2. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001 Oct 26;294(5543):858-62. (Pubitemid 33032104)
3. Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004 Sep 16;431(7006):343-9. (Pubitemid 39265674)
4. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006 Mar 27;94(6):776-80.
5. Huang YS, Dai Y, Yu XF, et al. Microarray analysis of micro RNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008 Jan; 23(l):87-94. (Pubitemid 350265207)
6. Wang Y, Lee AT, Ma JZ, et al. Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target. J Biol Chem 2008 May 9;283(19):13205-15.
7. Wong QW, Ching AK, Chan AW, et al. MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling. Clin Cancer Res 2010 Feb 1;16(3):867-75.
8. Chung GE, Yoon JH, Myung SJ, et al. High expression of micro RNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol Rep 2010 Jan; 23(1):113-9.
9. Huang XH, Wang Q, Chen JS, Fu XH, et al. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res 2009 Aug;39(8):-786-94.
10. Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma. Cancer Res 2007 Jul l;67(13):6092-9.
11. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 Apr 20;25(17):2537-45.
12. Varnholt H, Drebber U, Schulze F, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008 Apr;47(4):1223-32. (Pubitemid 351547908)
13. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005 Oct 27;353(17):1768-71.
14. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005 Jun 9;435(7043):834-8. (Pubitemid 40839735)
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001;25:402-8. (Pubitemid 34164012)
16. Jia HL, Ye QH, Qui LX, et al. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res 2007 Feb 15;13(4):1133-9.
17. Zhou J, Yu L, Gao X, et al. Plasma MicroRNA Panel to Diagnose Hepatitis B Virus-Related Hepatocellular Carcinoma. J Clin Oncol 2011 Dec 20;29(36):4781-8.
18. Cissell KA, Deo SK. Trends in microRNA detection. Anal Bioanal Chem 2009 Jun;394(4):1109-16.
19. Chen Y, Gelfond JA, McManus LM, Shireman PK. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 2009 Aug 28;10:407.
20. Li Y, Tan W, Neo TW, et al. Role of the miR-106b-25 micro RNA cluster in hepatocellular carcinoma. Cancer Sci 2009 Jul; 100(7):1234-42. Epub 2009 Apr 15.
21. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA Profiling in Hepatocellular Tumors Is Associated with Clinical Features and Oncogene/Tumor Suppressor Gene Mutations. Hepatology 2008 Jun;47(6):1955-63. (Pubitemid 351952843)
22. Sato F, Hatano E, Kitamura K, et al. MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria. PLoS One 2011 Jan 27;6(1):-el6435.
23. Li J, Fu H, Xu C, et al. miR-183 inhibits TGF-betal-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 2010 Jul 6;10:354.
24. Elyakim E, Sitbon E, Faerman A, et al. hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res 2010 Oct 15;70(20):8077-87.
25. He Y, Cui Y, Wang W, et al. Hypomethylation of the hsa-miR191 Locus Causes High Expression of hsa-miR-191 and Promotes the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Neoplasia 2011 Sep;13(9):841-53.
26. Zhou P, Jiang W, Wu L, Chang R, Wu K, Wang Z. miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene G ax in Human Hepatocellular Carcinoma. Dig Dis Sci 2012 Feb 29.
27. Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 2012 Mar 13.
28. Duan Q, Wang X, Gong W, et al. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulate tumor survival and progression in human hepatocellular cancer. PLoS One 2012;7(2):e31518.
29. Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010 Sep;38(16):5366-83.
30. Fornari F, Milazzo M, Chieco P, et al. MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. Cancer Res 2010 Jun 15;70(12):-5184-93.
31. Hou J, Lin L, Zhou W, et al. Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199ab-3p as Therapeutic Target for Hepatocellular Carcinoma. Cancer Cell. 2011 Feb 15;19(2):232-43.
32. Pineau P, Volinia S, McJunkin K, et al. miR-221 overexpression contribution to liver tumorigenesis. Proc Natl Acad Sci U S A 2010 Jan 5;107(1):264-9.
33. Su H, Yang JR, Xu T, et al. MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity. Cancer Res 2009 Feb 1;69(3):1135-42.
34. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D. Expression of MicroRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma and its Prognostic Significance. Mol Carcinog 2011 Dec 27 doi:10.1002/mc.21864.
35. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a Prevents Estrogen Receptor-Expression, Promoting Proliferation of Hepatocellular Carcinoma Cells. Gastroenterology 2009 Feb;136(2):683-93.
36. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010 Jan 29;17(1):F19-36.
37. Li XD, Li ZG, Song XX, Liu CF. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 2010 Dec;42(7):669-73.
38. Qi P, Dou TH, Geng L, et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 2010 Jun;71(6):621-6.
39. Akkiz H, Bayram S, Bekar A, Akgöllü E, Ulger Y. A functional polymorphism in pre-microRNA-l96a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat 2011 Jul;l8(7):e399-407 doi:-10.1111/j.1365-2893.2010.01414.x.
40. Wu X, Wu S, Tong L, et al. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. Scand J Gastroenterol 2009;44(11): 1332-9.